CorMedix Inc
F:19KA
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CorMedix Inc
F:19KA
|
US |
|
C
|
Cadence Design Systems Inc
XMUN:CDS
|
US |
|
C
|
Cadence Design Systems Inc
F:CDS
|
US |
|
D
|
Duke Energy Corp
DUS:D2MN
|
US |
|
G
|
GIBB River Diamonds Ltd
F:PHO
|
AU |
|
H
|
Hewlett Packard Enterprise Co
F:2HP
|
US |
Intrinsic Value
Is 19KA undervalued or overvalued?
See the intrinsic value estimate for 
CorMedix Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What CorMedix Does
CorMedix is a biopharmaceutical company focused on reducing infections tied to medical devices. Its main product is a catheter lock solution used inside central venous catheters to help prevent serious bloodstream infections, especially in patients who rely on long-term vascular access such as hemodialysis patients. In simple terms, the company sells a drug product designed to sit in the catheter when it is not in use and lower the chance that bacteria will grow there.
- Headquarters
- United States of America US
- Employees
- 191
- IPO date
- Mar 25, 2010
CorMedix has a narrow economic moat
CorMedix Inc has a narrow economic moat, offering limited protection against competitors and some ability to sustain profitability.
Read the full moat analysis
Revenue & Expenses Breakdown
CorMedix Inc
Earnings Waterfall
CorMedix Inc
The intrinsic value for CorMedix Inc (19KA) under the Base Case is hidden EUR.
Compared with the current market price of 4.605 EUR, the stock appears hidden.
